In conclusion, our research revealed TUG1 targeted miR‐34a to block the inhibitory effects of miR‐34a on DKK1, thereby inhibiting the activation of Wnt/β‐catenin signalling and alleviating cardiac hypertrophy. The gene discussed is DKK1; the disease is cardiac hypertrophy.